Developer of diagnostic tools designed to improve drug efficacy and patient outcomes. The company's technology platform leverages patient-derived micro-tumors to predict individual responses to an array of clinically relevant drugs to combat the widespread challenges of under- and over-treatment in oncological therapy, where many patients experience both ineffective treatments and harmful side effects, enabling clients to live longer lives through game-changing functional diagnostics in the fight against cancer.